BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3492847)

  • 1. Regulation of immunoglobulin synthesis by lymphocytes in multiple myeloma and benign monoclonal gammopathy.
    Takeshita A
    Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1195-205. PubMed ID: 3492847
    [No Abstract]   [Full Text] [Related]  

  • 2. [Subsets of T cells in myeloma, macroglobulinemia and benign monoclonal gammopathy: analysis of surface markers defined by monoclonal antibodies and the effect on Ig-synthesis by B cells].
    Okagawa K; Iguchi K; Iishi Y; Kosaka M
    Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1205-13. PubMed ID: 3934898
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of immunoglobulin synthesis by monocytes in multiple myeloma and benign monoclonal gammopathy.
    Takeshita A
    Clin Exp Immunol; 1986 Dec; 66(3):625-32. PubMed ID: 3568450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B lymphocyte markers in multiple myeloma and related plasma cell dyscrasias.
    Ricci C; Coscia G; Bozzone DM; Canavera RM; Baldassi R; Cascio G; Anania A; Marchi L; Verney MM
    Cancer Detect Prev; 1988; 11(3-6):423-32. PubMed ID: 3260538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Life-long observation of 21 patients with the M component in the serum].
    Nørgaard O
    Ugeskr Laeger; 1986 Oct; 148(43):2761-2. PubMed ID: 3787793
    [No Abstract]   [Full Text] [Related]  

  • 6. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
    Kelly JJ
    Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody activity of monoclonal immunoglobulins in myeloma, macroglobulinemia and benign gammapathy.
    Waldenström JG
    Med Oncol Tumor Pharmacother; 1986; 3(3-4):135-40. PubMed ID: 3100882
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating immunoglobulin secreting cells in patients in the premyelomatous state.
    Shimizu K
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1757-65. PubMed ID: 3105209
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dermatomyositis and monoclonal gammopathy].
    Wallach D; Carado Y; Foldès C; Cottenot F
    Ann Dermatol Venereol; 1985; 112(9):783-4. PubMed ID: 3937480
    [No Abstract]   [Full Text] [Related]  

  • 10. [The OKT4/OKT8 ratio in benign monoclonal gammopathies].
    La Rosa L; Mattoni C; La Rosa M
    Minerva Med; 1988 Dec; 79(12):1049-50. PubMed ID: 2974933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of lymphocyte subpopulations in multiple myeloma and monoclonal gammopathies of undetermined significance].
    Luraschi A; Fedeli P; Rossi M; Montanara S; Perlasca S; Cozzi S
    Minerva Med; 1986 Jun; 77(26):1235-41. PubMed ID: 3088491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy.
    Miguel-Garcia A; Matutes E; Tarin F; Garcia-Talavera J; Miguel-Sosa A; Carbonell F; Catovsky D
    J Clin Pathol; 1995 Sep; 48(9):835-9. PubMed ID: 7490317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic Q fever infection (Q fever endocarditis) with benign monoclonal gammopathy].
    Marschall HU; Döller G
    Internist (Berl); 1985 Oct; 26(10):640-2. PubMed ID: 3935597
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating B and T lymphocytes in myeloma and benign monoclonal gammopathies.
    Büchi G; Termine G; Girotto M; Gario S; Autino R
    Haematologica; 1983; 68(2):179-89. PubMed ID: 6407913
    [No Abstract]   [Full Text] [Related]  

  • 15. Surface markers and cytotoxic activities of lymphocytes in monoclonal gammopathy of undetermined significance and untreated multiple myeloma. Increased phytohemagglutinin-induced cellular cytotoxicity and inverted helper/suppressor cell ratio are features common to both diseases.
    De Rossi G; De Sanctis G; Bottari V; Tribalto M; Lopez M; Petrucci MT; Fontana L
    Cancer Immunol Immunother; 1987; 25(2):133-6. PubMed ID: 3664530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B and T lymphocytic populations and subpopulations and natural killer cells (NK) in blood of patients with myeloma and with monoclonal gammopathy of undetermined significance (MGUS).
    Büchi G; Girotto M; Termine G; Gario S; Grosso E; Autino R; Zappalà C
    Pathologica; 1985; 77(1050):385-93. PubMed ID: 3879633
    [No Abstract]   [Full Text] [Related]  

  • 17. Differentiation of benign monoclonal gammopathy and smouldering multiple myeloma from frank myeloma.
    Shimizu K; Ohnishi K; Kunii A
    Clin Exp Immunol; 1982 Dec; 50(3):596-600. PubMed ID: 6819908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thoracic changes in multiple myeloma and monoclonal gammopathy].
    Załeska J; Figura-Chojak E; Lesiak B; Wasowska H
    Pneumonol Pol; 1985; 53(11-12):546-53. PubMed ID: 3834409
    [No Abstract]   [Full Text] [Related]  

  • 19. [Monoclonal gammopathies].
    Macro M
    Rev Prat; 2008 Nov; 58(18):2071-7. PubMed ID: 19143282
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correlation between the IgG oligoclonal pattern and the benign nature of monoclonal abnormalities in the aged subject].
    Essakalli-Gharbi M; Abbal M; Tkaczuk J; Legrand MF; Adoue D; Ohayon E
    Pathol Biol (Paris); 1988 Feb; 36(2):133-8. PubMed ID: 3279380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.